CRISPR–Cas9 (clustered regularly interspaced short palindromic repeats [CRISPR]–CRISPR-associated protein 9 [Cas9]) technology has been widely applied to edit the genome of mammalian cells in vitro. Although this approach shows potential clinical usefulness and clinical trials have been initiated…